Atlas Trials

Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica

Clinical trial NCT04062006 · UNKNOWN

Trial details

NCT number
NCT04062006
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Polymyalgia Rheumatica
Start date
2019-08-31
Primary completion
2021-03-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.